ZURICH – Novartis (NYSE: NVS) expects to increase its annual sales by at least 5% per year in the coming […]
Novartis CEO ‘Very Confident’ on Sales Target, Doesn’t Fear Patent Cliff – Newspaper Read More »
On Thursday, Smith & Nephew (NYSE: SNN), the British medical equipment maker, cut its annual underlying revenue growth forecast due
Smith & Nephew (NYSE: SNN) Cuts Annual Revenue Growth Forecast, Stock Plummets Read More »
On Wednesday, the U.S. Centers for Disease Control and Prevention said that the number of infected people from the E.coli
Infections Linked to McDonald’s E. Coli Outbreak Rise to 90, US CDC Says Read More »
AstraZeneca’s (NASDAQ: AZN) China president is under investigation and is cooperating with Chinese authorities, the company said on Wednesday, sending
AstraZeneca (NASDAQ: AZN) Stock Falls on News of China President’s Investigation Read More »
On Wednesday, GSK (NYSE: GSK) said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory
FRANKFURT – Novartis, the Swiss drugmaker, raised its 2024 earnings guidance on Tuesday for the third time buoyed by wider
Novartis Lifts 2024 Earnings Outlook Again on Strong Cosentyx Demand Read More »
Novartis (NYSE: NVS), the Swiss pharmaceutical giant, will pay Monte Rosa Therapeutics (NASDAQ: GLUE) $150 million upfront payment for a
Novartis to Pay Monte Rosa $150 Million Upfront to Develop New Class of Drugs Read More »
On Friday, Sanofi (NASDAQ: SNY), the French drug maker, posted stronger earnings growth than analysts had expected in the third
Sanofi (NASDAQ: SNY) Posts Q3 Profit Beat on Early Start of Vaccine Sales Read More »
The February hack at UnitedHealth’s (NYSE: UNH) tech unit Change affected the personal information of 100 million people, the U.S.
UnitedHealth Tech Unit Hack Affected 100 Million People, US Health Dept Says Read More »
Copyright © 2024 abbonews.com
